Lauric Haber is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-HER antibodies. With a total of 2 patents, his work has the potential to impact cancer treatment and therapeutic approaches.

Latest Patents

Haber's latest patents focus on anti-HER antibodies, including multispecific anti-HER antibodies. The inventions provide compositions comprising these antibodies and methods of using them. Notably, the EGFR/HER3 multispecific antibodies developed by Haber are designed to be less toxic than traditional EGFR antagonists, offering a promising alternative in cancer therapies.

Career Highlights

Throughout his career, Lauric Haber has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in the field.

Collaborations

Haber has collaborated with esteemed colleagues such as Germaine G. Fuh and Gabriele Maria Schaefer. These partnerships have further enhanced his research and development efforts in the biotechnology arena.

Conclusion

Lauric Haber stands out as an influential inventor in the realm of anti-HER antibodies. His innovative work and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.